SCHEMBL20138800

SCHEMBL20138800

O=C(N[C@H]1CC[C@H](C(=O)Nc2cnccc2Cl)CC1)c1cccc2nccnc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 5/20 0.51
▸ GSK3A P49840 3/20 0.51
▸ P2RX7 Q99572 1/20 0.45
▸ PIM1 P11309 3/20 0.42
▸ MAPT P10636 2/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ PIM2 Q9P1W9 1/20 0.42
▸ TNKS2 Q9H2K2 2/20 0.42
▸ TNKS O95271 1/20 0.42
▸ MCL1 Q07820 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ DGAT1 O75907 1/20 0.40
▸ LMNA P02545 2/20 0.39
▸ TP53 P04637 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ PTBP1 P26599 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ ESR1 P03372 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20138801 1.00 GSK3B (0.51) GSK3BGSK3AP2RX7PIM1MAPT
SCHEMBL20138814 0.89 GSK3A (0.51) GSK3BGSK3AP2RX7PIM1PIM2
SCHEMBL20138815 0.89 GSK3A (0.51) GSK3BGSK3AP2RX7PIM1PIM2
SCHEMBL20139008 0.84 LMNA (0.52) GSK3BGSK3AP2RX7MAPTHSD17B10
SCHEMBL20139011 0.84 LMNA (0.52) GSK3BGSK3AP2RX7MAPTHSD17B10
SCHEMBL20138817 0.81 KCNH2 (0.51) GSK3BGSK3AMAPT
SCHEMBL20138818 0.81 KCNH2 (0.51) GSK3BGSK3AMAPT
SCHEMBL20138847 0.80 GSK3A (0.56) GSK3BGSK3AMAPTMCL1KMT2A
SCHEMBL20138846 0.80 GSK3A (0.56) GSK3BGSK3AMAPTMCL1KMT2A
SCHEMBL18208170 0.78 GSK3B (0.58) GSK3BGSK3AMAPTKMT2AABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018087126-A1 AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES AS INHIBITORS OF TANKYRASE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-05-17 — — WO claimed
WO-2018087126-A1 AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES AS INHIBITORS OF TANKYRASE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-05-17 — — WO disclosed
WO-2018087126-A1 AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES AS INHIBITORS OF TANKYRASE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-05-17 — — WO disclosed
Send feedback